Picture of Indaptus Therapeutics logo

INDP — Indaptus Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Brief: Indaptus Therapeutics Announces Positive Results From Second Cohort Of Phase 1 Trial

March 4 (Reuters) - Indaptus Therapeutics Inc  INDP.O :
    * INDAPTUS THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM
SECOND
COHORT OF PHASE 1 TRIAL; COMPANY INITIATES MULTI-DOSE COHORT
    * INDAPTUS THERAPEUTICS INC - SINGLE DOSE COHORT DATA
EXPECTED TO
BE PUBLISHED AT A SCIENTIFIC CONFERENCE IN 2024
    * INDAPTUS THERAPEUTICS INC - PATIENTS CONTINUE TO EXHIBIT A
BROAD
IMMUNE RESPONSE SIMILAR TO FIRST COHORT

Source text for Eikon:  ID:nGNX5X2HGy 
Further company coverage:  INDP.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Indaptus Therapeutics

See all news